AI assistant
SUPERNUS PHARMACEUTICALS, INC. — Director's Dealing 2012
Apr 30, 2012
31512_dirs_2012-04-30_49146b9a-a3cc-4495-a40a-c8510ac66b68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SUPERNUS PHARMACEUTICALS INC (SUPN)
CIK: 0001356576
Period of Report: 2012-04-30
Reporting Person: Bhatt Padmanabh P. (Sr. VP of IP; CSO)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $0.40 | 2016-01-17 | Common Stock (50000) | Direct | |
| Employee Stock Option (right to buy) | $0.40 | 2016-01-17 | Common Stock (6250) | Direct | |
| Employee Stock Option (right to buy) | $0.40 | 2016-01-17 | Common Stock (6250) | Direct | |
| Employee Stock Option (right to buy) | $0.40 | 2017-02-13 | Common Stock (3000) | Direct | |
| Employee Stock Option (right to buy) | $3.36 | 2020-02-10 | Common Stock (2500) | Direct | |
| Employee Stock Option (right to buy) | $2.56 | 2020-11-02 | Common Stock (37500) | Direct |
Footnotes
F1: 25% of the shares subject to the option vested on 1/17/2007, and the remaining shares subject to the option vested in approximately equal quarterly installments over the following three years.
F2: 25% of the shares subject to the option vested on 2/13/2008, and the remaining shares subject to the option vested in approximately equal quarterly installments over the following three years.
F3: 25% of the shares subject to the option vested on each of 2/10/2011 and 2/10/2012, and the remaining shares subject to the option will vest in approximately equal installments on 2/10/13 and 2/10/14.
F4: 25% of the shares subject to the option vested on 11/2/2011, and the remaining shares subject to the option will vest in approximately equal quarterly installments over the following three years.